Type
Walsh G, Cruz E, Abalos R, Tan E, Fajardo T, Villahermosa L, et al. Limited susceptibility of cynomolgus monkeys (Macaca fascicularis) to leprosy after experimental administration of Mycobacterium leprae. The American journal of tropical medicine and hygiene. 2012;87(2):327-36.
Type
van Brakel WH, Sihombing B, Djarir H, Beise K, Kusumawardhani L, Yulihane R, et al. Disability in people affected by leprosy: the role of impairment, activity, social participation, stigma and discrimination. Global health action [Internet]. 2012;5. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402069/pdf/GHA-5-18394.pdf
Type
Ribeiro S, Pereira H, Mangueira CL, Ferreira C, Rosseto E, Scheinberg M. The development of arthritis and antinuclear antibodies correlate with serum 25-hydroxyvitamin D levels in patients with leprosy. Annals of the rheumatic diseases. 2012;71(12):2062-3.
Type
Henriques CC, Lopéz B, Mestre T, Grima B, Panarra A, Riso N. Leprosy and rheumatoid arthritis: consequence or association?. BMJ case reports. 2012;2012.
Type
Bourée P, Carsalade G-Y. [Current status of leprosy]. La Revue du praticien. 2012;62(6):751-5.
Type
Hacker M, Sales A, Illarramendi X, Nery J, Duppre N, Bastos F, et al. A profile of patients treated at a national leprosy outpatient referral clinic in Rio de Janeiro, Brazil, 1986-2007. Revista panamericana de salud publica = Pan American journal of public health [Internet]. 2012;31(6):485-91. Available from: http://www.scielosp.org/pdf/rpsp/v31n6/v31n6a06.pdf
Type
Thai, Huong, Ba, Schurr, Truman, Alcais, et al. PARK2 Mediates Interleukin 6 and Monocyte Chemoattractant Protein 1 Production by Human Macrophages. PLoS neglected tropical diseases [Internet]. 2013;7(1):e2015. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547867/pdf/pntd.0002015.pdf
Type
Kapata N, Chanda-Kapata P, Grobusch MP, O'Grady J, Bates M, Mwaba P, et al. Leprosy trends in Zambia 1991-2009. Tropical medicine & international health : TM & IH [Internet]. 2012;17(10):1289-93. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-3156.2012.03050.x/epdf
Type
Kumar A, Girdhar A, Girdhar BK. Six months fixed duration multidrug therapy in paucibacillary leprosy: risk of relapse and disability in Agra PB cohort study. BMJ Open [Internet]. 2012;2(4):e001403. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425897/pdf/bmjopen-2012-001403.pdf
Type
Nardi SMT, Paschoal VDA, Zanetta DMT, Chiaravalloti-Neto F. [Leprosy-related disabilities after release from multidrug treatment: prevalence and spatial distribution.]. Revista de saude publica [Internet]. 2013;. Available from: http://www.scielosp.org/pdf/rsp/2013nahead/ao4048.pdf